Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management.

IF 4.3 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Obstetrical & Gynecological Survey Pub Date : 2024-11-01 DOI:10.1097/OGX.0000000000001326
Courtney A Bair, Jennifer Cate, Allison Chu, Jeffrey A Kuller, Sarah K Dotters-Katz
{"title":"Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management.","authors":"Courtney A Bair, Jennifer Cate, Allison Chu, Jeffrey A Kuller, Sarah K Dotters-Katz","doi":"10.1097/OGX.0000000000001326","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Fetal macrosomia (FM) is common in clinical practice and carries increased risk of adverse maternal and neonatal health outcomes. Maternal diabetes mellitus (DM) is a well-known cause of macrosomia with significant research and guidelines focusing on macrosomia in this population. Less is known about causes, prevention, and clinical management for suspected FM in individuals without diabetes.</p><p><strong>Objective: </strong>The objective of this review is to describe the risk factors associated with nondiabetic FM, review risks associated with macrosomia in pregnancy, and potential treatment considerations for this condition.</p><p><strong>Evidence acquisition: </strong>Original research articles, review articles, and guidelines on macrosomia were reviewed.</p><p><strong>Results: </strong>Risk factors for macrosomia in patients without DM include previous delivery of an infant with macrosomia, excessive pregnancy weight gain, and obesity. Maternal complications of FM include higher rates of cesarean delivery, postpartum hemorrhage, and vaginal laceration. Fetal complications include shoulder dystocia, decreased Apgar scores, and increased risk of childhood obesity. Exercise during pregnancy has been shown to reduce the risk of FM. Induction of labor prior to 39 weeks is not recommended in the setting of suspected macrosomia as there is a lack of adequate evidence to support that this decreases adverse neonatal or maternal outcomes. In addition, elective cesarean delivery for suspected macrosomia is not recommended to be considered unless estimated fetal weight is greater than 5000 g in the absence of DM.</p><p><strong>Conclusions and relevance: </strong>Delivery of an infant with macrosomia in patients without DM has increased maternal and fetal risks. Predicting infants who will meet criteria for macrosomia is challenging. More research is needed to identify ways to accurately estimate fetal weight, interventions to prevent macrosomia, and additional ways to mitigate risk in patients without DM who have suspected FM.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"79 11","pages":"653-664"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrical & Gynecological Survey","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/OGX.0000000000001326","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Fetal macrosomia (FM) is common in clinical practice and carries increased risk of adverse maternal and neonatal health outcomes. Maternal diabetes mellitus (DM) is a well-known cause of macrosomia with significant research and guidelines focusing on macrosomia in this population. Less is known about causes, prevention, and clinical management for suspected FM in individuals without diabetes.

Objective: The objective of this review is to describe the risk factors associated with nondiabetic FM, review risks associated with macrosomia in pregnancy, and potential treatment considerations for this condition.

Evidence acquisition: Original research articles, review articles, and guidelines on macrosomia were reviewed.

Results: Risk factors for macrosomia in patients without DM include previous delivery of an infant with macrosomia, excessive pregnancy weight gain, and obesity. Maternal complications of FM include higher rates of cesarean delivery, postpartum hemorrhage, and vaginal laceration. Fetal complications include shoulder dystocia, decreased Apgar scores, and increased risk of childhood obesity. Exercise during pregnancy has been shown to reduce the risk of FM. Induction of labor prior to 39 weeks is not recommended in the setting of suspected macrosomia as there is a lack of adequate evidence to support that this decreases adverse neonatal or maternal outcomes. In addition, elective cesarean delivery for suspected macrosomia is not recommended to be considered unless estimated fetal weight is greater than 5000 g in the absence of DM.

Conclusions and relevance: Delivery of an infant with macrosomia in patients without DM has increased maternal and fetal risks. Predicting infants who will meet criteria for macrosomia is challenging. More research is needed to identify ways to accurately estimate fetal weight, interventions to prevent macrosomia, and additional ways to mitigate risk in patients without DM who have suspected FM.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非糖尿病胎儿巨大畸形:原因、结果和临床管理。
重要性:胎儿巨大儿(FM)在临床实践中很常见,会增加孕产妇和新生儿不良健康后果的风险。孕产妇糖尿病(DM)是导致巨大胎儿症的一个众所周知的原因,针对这一人群的巨大胎儿症进行了大量研究并制定了相关指南。而对于无糖尿病的个体中疑似肥胖症的病因、预防和临床管理则知之甚少:本综述旨在描述与非糖尿病 FM 相关的风险因素,回顾与妊娠期巨型畸形相关的风险,以及该病症的潜在治疗注意事项:结果:妊娠期巨型畸形的风险因素有哪些?结果:非糖尿病患者出现巨大儿的风险因素包括曾分娩过巨大儿婴儿、孕期体重增加过多以及肥胖。巨大胎儿症的母体并发症包括较高的剖宫产率、产后出血和阴道裂伤。胎儿并发症包括肩难产、Apgar 评分下降和儿童肥胖风险增加。事实证明,孕期运动可降低发生 FM 的风险。在怀疑有巨大儿的情况下,不建议在 39 周前引产,因为缺乏足够的证据证明这会降低新生儿或孕产妇的不良预后。此外,除非在没有DM的情况下估计胎儿体重超过5000克,否则不建议考虑对疑似巨大儿进行选择性剖宫产:无DM患者分娩巨大儿会增加母体和胎儿的风险。预测符合巨大儿标准的婴儿具有挑战性。需要进行更多的研究,以确定准确估计胎儿体重的方法、预防巨大儿的干预措施,以及降低无 DM 但疑似有 FM 的患者风险的其他方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
3.20%
发文量
245
审稿时长
>12 weeks
期刊介绍: ​Each monthly issue of Obstetrical & Gynecological Survey presents summaries of the most timely and clinically relevant research being published worldwide. These concise, easy-to-read summaries provide expert insight into how to apply the latest research to patient care. The accompanying editorial commentary puts the studies into perspective and supplies authoritative guidance. The result is a valuable, time-saving resource for busy clinicians.
期刊最新文献
Autologous Ovarian Tissue Transplantation: Preoperative Assessment and Preparation of the Patient. Disparities in Genetic Management of Breast and Ovarian Cancer Patients. Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management. Treatment of Obesity Before, During, and After Pregnancy: Time for Obstetricians to Get Involved. Diagnosis and Management of Preterm Prelabor Rupture of Membranes: A Comprehensive Review of Major Guidelines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1